[Respiratory syncitial virus in immunocompromised patients in a pediatric hospital: 5 years experience]
- PMID: 24890887
- DOI: 10.1016/j.anpedi.2014.04.016
[Respiratory syncitial virus in immunocompromised patients in a pediatric hospital: 5 years experience]
Abstract
Introduction: Respiratory syncytial virus (RSV) infection is associated with an increase in morbidity and mortality in immunocompromised hosts.
Methods: A description is presented of all cases of RSV infection in immunocompromised pediatric patients in Hematology and Oncology and Immunodeficiency Units between 2008 and 2012.
Results: Nineteen patients were diagnosed with RSV infection. Nine patients required in-patient care and 2 required Pediatric Intensive Care Unit. Five patients were treated with specific therapy (ribavirin ± palivizumab). No deaths occurred in the study period.
Conclusion: RSV infection may be severe in immunocompromised pediatric patients.
Keywords: ECMO; Immunocompromised Host; Inmunodeprimido; Palivizumab; Respiratory syncytial virus; Ribavirin; Ribavirina; Virus respiratorio sincitial.
Copyright © 2014 Asociación Española de Pediatría. Published by Elsevier Espana. All rights reserved.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
